Abstract. Diabetic patients undergoing hemodialysis demonstrate much worse survival rates than do nondiabetic patients undergoing hemodialysis. To search for risk predictors, a prospective cohort study was performed with 245 hemodialysis patients, including 84 with diabetes mellitus, for 2 yr. C-reactive protein, troponin T (TnT), total, HDL, LDL, and lipoprotein(a) cholesterol, apoA2, apoB, triglyceride, fibrinogen, Ddimer, albumin, and creatinine levels and clinical characteristics at the time of entry were recorded. Survival rates were compared with Kaplan-Meier and Cox regression analyses. Forty-three diabetic patients and 30 nondiabetic patients died. Among diabetic patients, oliguria (Ͻ200 ml/d) (relative risk, 3.24; 95% confidence interval, 1.63 to 6.41; P ϭ 0.001), elevated C-reactive protein levels (relative risk, 2.57; 95% confidence interval, 1.06 to 6.18; P ϭ 0.035), and elevated D-dimer levels (relative risk, 2.36; 95% confidence interval, 1.11 to 5.01; P ϭ 0.025) predicted all-cause mortality rates. Oliguria was by far the most important predictor, particularly for infectious disease-related death (relative risk, 23.35; 95% confidence interval, 2.60 to 209.97; P ϭ 0.005). Among nondiabetic patients, elevated TnT levels (relative risk, 4.00; 95% confidence interval, 1.58 to 10.10; P ϭ 0.003), elevated D-dimer levels (relative risk, 3.45; 95% confidence interval, 1.27 to 9.33; P ϭ 0.015), and low cholesterol levels (relative risk, 3.61; 95% confidence interval, 1.34 to 9.71; P ϭ 0.011) predicted all-cause mortality rates. Subdivision of the causes of death among nondiabetic patients revealed that TnT levels predicted cardiovascular mortality rates (relative risk, 5.38; 95% confidence interval, 1.11 to 26.10; P ϭ 0.037) and infectious disease-related mortality rates (relative risk, 12.02; 95% confidence interval, 1.42 to 191.96; P ϭ 0.023). In conclusion, mortality predictors among patients undergoing hemodialysis differed substantially between diabetic and nondiabetic patients. Strategies to reduce mortality rates should consider these differences.
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Hemodialysis techniques have improved remarkably in recent decades, and prospective randomized trials have been conducted to improve outcomes among patients undergoing dialysis. A well accepted, albeit complex, set of guidelines has been established in the United States and Europe to ensure the quality of dialysis care. However, outcomes remain poor (1) (2) (3) . Cardiovascular disease is the most common cause of death, and infectious causes are second in frequency (4, 5) . Dialysis-related strategies have not been successful in reducing mortality rates. The underlying renal disease, preexisting coronary artery disease, malnutrition, systemic inflammation [as indicated by C-reactive protein (CrP) levels], elevated levels of cardiac enzymes [notably troponin T (TnT)], and poor residual renal function (oliguria) have all been identified as risk factors (6 -12) . Diabetes mellitus is the most important clinical risk factor; diabetic patients have a life expectancy with dialysis of Ͻ5 yr. The risk factors unique to these high-risk patients have not been delineated. We conducted a prospective cohort study of 245 patients undergoing dialysis (84 with diabetes mellitus and 161 without diabetes mellitus), to evaluate and compare risk factors.
Materials and Methods
We studied 245 patients undergoing dialysis, who were recruited from two dialysis centers in Berlin, Germany, associated with our inpatient facility at the Charité Campus Mitte, Humboldt University of Berlin. The two dialysis centers are nonproprietary units of the Kuratorium für Heimdialyse (Neu Isenburg, Germany), a unique, notfor-profit facility that treats approximately one-half of the patients undergoing chronic dialysis in Germany. The Kuratorium für Heimdialyse prescribes a high quality of care, corresponding to the United States Disease Outcomes Quality Initiative guidelines, and monitors care with computerized data acquisition. Patients undergo dialysis at least three times per week, in 4-to 6-h sessions, to achieve Kt/V values of at least 1.3.
The cohort was recruited in March 2000. Written informed consent was obtained from all participants, after institutional review board approval. We excluded patients with malignancies, chronic infections (such as osteomyelitis), or conditions that might affect the tested serum parameters (see below). All patients had a functioning permanent access device. The initial documentation included age, gender, underlying renal disease, residual renal function and urinary output, presence of diabetes mellitus, hypertension (a need for any antihypertensive drug), smoking, and/or heart disease, and coronary status. Physicians from our department staff both dialysis units, and our hospital is the sole inpatient care provider. Blood samples were obtained from all studied patients in March 2000, in our dialysis facilities, immediately before dialysis. The patients were monitored for exactly 775 d, beginning with the day of blood sampling. All patients were asked to collect their urine for 24 h, beginning after the dialysis session at which the blood samples were obtained in March 2000. Urine sampling was repeated 1 wk later, to assess the reliability of urine sampling. We individually evaluated all deaths and reviewed the records. Autopsies were obtained in as many instances as possible. Patients who received a transplant were censored at the time of transplantation. A change in treatment modality (initiation of peritoneal dialysis) was also a censoring event.
Albumin, protein, creatinine, cholesterol, triglyceride, apoB, apoA1, lipoprotein(a), fibrinogen, and D-dimer levels were measured with standardized autoanalyzer methods (Hitachi 747, Hitachi 911, and STA analyzers; Roche Diagnostics, Mannheim, Germany). HDL and LDL cholesterol levels were directly measured with a commercially available, immunoseparation-based assay, followed by a selective enzymatic colorimetric assay (Rolf Greiner BioChemicals, Flacht, Germany). CrP levels were measured with standardized methods in an autoanalyzer (Dimension RxL; Behring Vertriebs, Schwalbach, Germany). TnT levels were measured with an Elecsys system 2010 (Roche Diagnostics). All measured parameters were subject to quality control management and were certified according to the guidelines of the German Society of Clinical Chemistry.
An initial univariate analysis compared the frequency of possible risk factors for death among patients undergoing hemodialysis. Categorical data were compared by using the chi-squared test. Continuous variables were assessed with t tests, after testing for normal distribution with the Kolmogorov-Smirnov test. We analyzed all tested serum parameters [CrP, TnT, cholesterol, HDL, LDL, albumin, creatinine, lipoprotein(a), apoA1, apoB, fibrinogen, D-dimer, and triglyceride levels] by using the area under the receiver operating command curve. When the receiver operating command curve is plotted with 1 Ϫ specificity on the abscissa and the corresponding values for sensitivity on the ordinate, the point of the receiver operating command curve closest to the upper left corner of the coordinate system (where sensitivity and specificity equal 1) represents the best cutoff value. This cutoff value was calculated and used to transform individual continuous parameters into binary endpoints. Survival rates were compared by using the Kaplan-Meier method and were tested for significant differences with the log rank test. To control for possible confounding, we performed Cox regression analyses with factors [age, preexisting coronary artery disease, oliguria (more or less than 200 ml/d), and TnT, CrP, D-dimer, albumin, HDL, creatinine, and cholesterol levels] that demonstrated significant (P Ͻ 0.01) effects on the endpoint of all-cause death in analyses of Kaplan-Meier survival curves with the log rank test. Diabetes mellitus also demonstrated significant effects on all-cause mortality rates in the univariate analysis and was thus included in an additional Cox regression analysis, for determination of the effects of diabetes mellitus on mortality rates. Cox regression analyses were performed for all-cause death, death attributable to cardiovascular disease, and death attributable to infectious diseases. The proportional-hazards assumption, i.e., that the effects of regressors on mortality rates do not vary with time, was assessed by using interaction terms for three follow-up periods (0 to 258, 259 to 517, and 518 to 775 d), defined as tertiles of the follow-up time of 775 d. This analysis revealed constant effects of regressors on mortality rates with time. All data were analyzed by using SPSS for Windows, version 11.0 (SPSS, Inc., Chicago, IL).
Results
We screened all 259 patients who were treated in March 2000 in the two dialysis units. Fourteen patients were not included, for the following reasons: shunt thrombosis (four patients), shunt infections (two patients), myocardial infarctions within the previous 3 wk (two patients), chronic osteomyelitis (two patients), pneumonia (two patients), and cancer (two patients). The remaining 245 patients (duration of dialysis, 3 wk to 21 yr; median, 4.3 yr) were included; none of the 245 patient was lost to follow-up monitoring. Twenty-two patients exhibited seropositivity for hepatitis C virus; none of the 245 patients exhibited seropositivity for hepatitis B virus or HIV. Eighty-four patients were diabetic (five with type 1 diabetes mellitus and 79 with type 2 diabetes mellitus). Sixtyfive of those patients most likely had diabetic nephropathy. In most cases, the diagnosis was based on clinical criteria (a history of proteinuria without hematuria, typical ultrasonographic findings, and an absence of any clinical sign of other underlying kidney diseases). Thirty-eight patients demonstrated hypertensive nephrosclerosis. The remainder had various glomerular diseases or other conditions (Table 1) . For 40 patients, the underlying renal disease was unknown. Seventythree patients died, including more than one-half of the diabetic patients and one-third of the patients with hypertensive nephrosclerosis. Demographic data and laboratory values are provided in Table 2 . The cohort had a mean age of 63.5 yr, reflecting the current dialysis population in Berlin. Patients who died had a mean age of 70.4 yr.
Forty-one patients died as a result of cardiovascular disease, including 10 with acute myocardial infarctions, 15 with sudden cardiac death, and 14 with chronic heart failure. Patients who died as a result of cardiovascular disease more commonly had diabetes mellitus, hypertension, lower serum albumin and cholesterol concentrations, and higher CrP and TnT levels, compared with survivors. Infection was the second most common cause of death, involving 23 patients. Eighteen patients died as a result of sepsis. Pneumonia, pseudomembranous colitis, and tuberculosis were far less common causes. Patients who died as a result of infection were also more commonly diabetic, compared with survivors. Those patients were also far more likely to have oliguria (Ͻ200 ml/d). Five patients developed cancer and died. Two patients died in accidents (trauma), and one patient died as a result of hyperkalemia. For one patient, the cause of death could not be determined; that patient died while away from Berlin.
Residual renal function, as reflected by diuresis, had a strong effect on the risk of death resulting from infection, compared with cardiovascular disease (Figure 1 ). In contrast, serum TnT levels had strong effects on cardiovascular death and death attributable to infectious causes (Figure 2 ). Univariate analyses of potential predictors of all-cause mortality rates (we performed Kaplan-Meier survival analyses and log rank tests for all factors listed in Table 2 ) revealed that age (P ϭ 0.0078), diabetes mellitus (P Ͻ 0.0001), oliguria (P ϭ 0.0019), coronary artery disease (P ϭ 0.0038), CrP levels (P ϭ 0.0008), fibrinogen levels (P ϭ 0.0169), D-dimer levels (P Ͻ 0.0001), and time on dialysis (P ϭ 0.0438) had direct effects on mortality rates. Hypertension (P ϭ 0.0292) and serum albumin (P Ͻ 0.0001), LDL (P ϭ 0.02246), HDL (P ϭ 0.0012), total cholesterol (P ϭ 0.0004), and creatinine (P ϭ 0.0018) levels had inverse effects. All other factors listed in Table 2 had no significant effects on all-cause mortality rates, as indicated by log rank tests of Kaplan-Meier survival curves.
The results of Cox regression analyses for the total population with respect to all-cause mortality rates, cardiovascular disease-related mortality rates, and infection-related mortality rates are presented in Table 3 . Preexisting coronary artery disease, oliguria (Ͻ200 ml/d), elevated TnT levels, elevated D-dimer levels, and low HDL levels entered the regression and were significantly associated with overall mortality rates. For patients who died as a result of infection, elevated TnT levels, low albumin levels, and oliguria (Ͻ200 ml/d) were the strongest predictors of death, distinguishing those patients from patients who died as a result of cardiovascular disease. Cox regression analysis including all factors (diabetes mellitus, age, preexisting coronary artery disease, oliguria, and TnT, CrP, D-dimer, albumin, HDL cholesterol, creatinine, and total cho- lesterol levels) that demonstrated major (P Ͻ 0.01) effects on all-cause mortality rates in the log rank tests of Kaplan-Meier survival curves revealed that diabetes mellitus was an important risk factor predicting all-cause death (relative risk, 2.388; 95% confidence interval, 1.399 to 4.070; P ϭ 0.001) in the whole study population.
Oliguria of Ͻ200 ml/d was the most important risk factor predicting all-cause mortality rates among patients with diabetes mellitus but was not significantly associated with all-cause mortality rates among nondiabetic patients with ESRD ( Figure 1 and Tables 4 and 5 ). CrP levels had significant independent effects on all-cause mortality rates among diabetic patients and were not significantly associated with mortality rates among nondiabetic patients (Tables  4 and 5 ). HDL levels were significantly associated only with all-cause mortality rates among diabetic patients with ESRD (Tables 4 and 5 ). Elevated D-dimer levels had effects on survival rates for both groups (Tables 4 and 5 ). It is noteworthy that none of the risk factors that were included in the Cox regression analysis had significant effects on death Figure 2 . Kaplan-Meier survival analyses, according to troponin T (TnT) levels, for cardiovascular death (a, c, and e) and death attributable to infectious diseases (b, d, and f) among all patients with ESRD (a and b), as well as patients with ESRD with (c and d) and without (e and f) diabetes mellitus. Using receiver operating command curves, we calculated the cutoff value for TnT levels as 0.054 g/liter. Solid lines, patients with TnT levels of Ͻ0.054 g/liter; dotted lines, patients with TnT levels of Ͼ0.054 g/liter. Survival rates were compared with the log rank test.
resulting from cardiovascular disease among diabetic patients with ESRD (Table 4) . Only low HDL cholesterol levels demonstrated a trend (P ϭ 0.054) as a risk factor for cardiovascular death among diabetic patients with ESRD. Oliguria (Ͻ200 ml/d) was a very important risk factor for death resulting from infectious diseases (relative risk, 23.35; 95% confidence interval, 2.59 to 209.9) among diabetic patients undergoing hemodialysis ( Figure 1 and Table 4 ).
The most important factor determining all-cause mortality rates among nondiabetic patients with ESRD was TnT levels, followed by cholesterol, D-dimer, and albumin levels ( Table   5 ). TnT levels represented an important risk factor for both cardiovascular death and death attributable to infectious diseases ( Figure 2) .
Cox regression analysis of deaths attributable to cardiovascular disease revealed that only elevated TnT concentrations were a significant risk factor for nondiabetic patients with ESRD. The other factors were less important (Table 5) . Death attributable to infectious diseases among nondiabetic patients with ESRD, however, was significantly associated with oliguria (Ͻ200 ml/d), elevated TnT levels, and low serum albumin levels ( Figures 1 and 2 and Table 5 ). a The cutoff value for each continuous parameter was determined by using the receiver operating command curve for that parameter. 95% CI, 95% confidence interval. TnT levels, followed by the presence of coronary artery disease, oliguria (Ͻ200 ml/d), and elevated Ddimer levels, were the most important independent factors predicting all-cause mortality rates for the entire study population. a The cutoff value for each continuous parameter was determined by using the receiver operating command curve for that parameter. 95% CI, 95% confidence interval. Oliguria (Ͻ200 ml/day), followed by elevated CrP and D-dimer levels, were the most important independent factors predicting all-cause mortality rates for patients with diabetes mellitus.
Discussion
Risk factors predicting all-cause mortality rates among patients with ESRD undergoing hemodialysis have been well described. Our study adds a new aspect to these important studies, namely, the comparison of risk factors predicting cardiovascular and infectious disease-related mortality rates among diabetic and nondiabetic patients with ESRD. Our study is the first prospective study indicating that mortality predictors for diabetic and nondiabetic patients undergoing dialysis differ markedly. Diabetic patients demonstrated a higher mortality risk, compared with nondiabetic patients. Oliguria, elevated CrP levels, and elevated D-dimer levels were important for this group. Oliguria was associated with increased infectious disease-related mortality risk, regardless of diabetes mellitus status. Among nondiabetic patients, elevated TnT levels, elevated D-dimer levels, and low cholesterol concentrations were strong predictors. Among those patients, high TnT levels were associated with both cardiovascular and infectious disease-related death. Our findings suggest that therapeutic strategies to reduce mortality rates should consider these important differences in risk factor profiles for diabetic and nondiabetic patients with ESRD.
Although the main goal of our study was to compare factors predicting mortality rates among diabetic and nondiabetic patients with ESRD, we were also able to confirm the effects of more-conventional risk factors in predicting all-cause mortality rates among patients with ESRD (4 -12). Kaplan-Meier analysis of survival curves demonstrated that factors such as preexisting coronary artery disease, elevated CrP levels, low serum albumin levels, and increased TnT levels were predictors of all-cause mortality rates for the whole study population. These findings indicate that our study population was representative of patients with ESRD undergoing hemodialysis and that the conclusions of our study are of general applicability. In agreement with other studies, we could also demonstrate that the effects of some risk factors in predicting all-cause mortality rates among patients undergoing hemodialysis differed from those in the general population. Age remained a predominant factor. Smoking and gender seemed to be less important. The smoking risk might have been underestimated, because many of our dialysis patients had stopped smoking for various reasons when they became chronically ill. We did not focus on life-long smoking habits among our patients. Our data confirmed earlier observations that, among hemodialysis patients, cholesterol and LDL levels are inversely rather than directly associated with mortality rates, even for death resulting from cardiovascular causes (13, 14) . This observation is probably related to the fact that, among these patients, cholesterol concentrations reflect overall nutrition and health. In support of that idea is the observation that HDL levels in general remain inversely associated with cardiovascular mortality rates. The effects of hypertension on mortality rates also seem to be different from those in the general population. We observed that patients with ESRD who were being treated with antihypertensive drugs at the time of study entry exhibited somewhat improved survival rates. This finding is in good agreement with the results of a recent prospective study by Salem and Bower (15) , which indicated that treated hypertensive patients demonstrated approximately one-half the risk of dying, compared with patients without antihypertensive drug treatment. It was suggested that antihypertensive drug treatment itself might be cardioprotective, independent of the direct BP effects (15, 16) . In addition, there is evidence that BP is not directly related to mortality risk among patients with ESRD. Studies noted a U-shaped mortality risk curve with respect to BP for patients with ESRD (16) . Both high and low BP had adverse effects on mortality rates. BP within the high normal range, as a The cutoff value for each continuous parameter was determined by using the receiver operating command curve for that parameter. 95% CI, 95% confidence interval. Elevated TnT levels, elevated D-dimer levels, and low cholesterol levels were the most important independent factors predicting all-cause mortality rates for patients without diabetes mellitus.
achieved with drug treatment in our population, was associated with a lower mortality risk.
We were impressed by the strong effects of oliguria on infectious disease-related risk among our patients. The effects of oliguria on the risk of fatal infectious diseases were especially important for diabetic patients with ESRD. We have no reason to think that extracellular fluid volume is responsible, because review of the records demonstrated no difference in interdialytic weight gain between oliguric survivors and nonsurvivors. Residual renal function might facilitate volume control (17, 18) . Therefore, diuresis of Ͼ200 ml/d might have beneficial effects on cardiovascular mortality rates. However, this was not observed for diabetic or nondiabetic patients undergoing hemodialysis. In contrast, our data indicated that residual diuresis was particularly important for the risk of fatal infectious diseases (mainly sepsis), especially among diabetic patients. Our findings are in agreement with the results of an earlier study of patients with ESRD undergoing hemodialysis, which demonstrated that residual renal function was an independent predictor of all-cause mortality rates (19) . Among patients treated with peritoneal dialysis, however, several studies have demonstrated that low residual renal function is a risk factor for all-cause death (20 -22) . We think that residual renal function might facilitate the elimination of inflammatory mediators (20, 23) or improve overall health, because even a small degree of remaining renal function can have a large effect on overall well-being among dialysis patients. This hypothesis is in accord with a recent study of patients with ESRD undergoing peritoneal dialysis, which demonstrated an inverse relationship between inflammation and residual renal function (20) . Sepsis was a common cause of infectious disease-related death among our patients, although the vast majority of our patients had native fistulae, rather than synthetic grafts.
In agreement with earlier studies, we observed an effect of CrP as a mortality predictor (24 -26) . Among our patients, diabetic patients, rather than nondiabetic patients, determined the CrP results. Inflammation plays a central role in arteriosclerosis. For example, CrP colocalizes with complement C5b-9 in early atherosclerotic lesions and may fulfill a complement-activating function, thus exerting direct effects (21). The strong effects among diabetic patients may reflect the effects of hyperglycemia on diacylglycerol levels and protein kinase C activation. Nuclear factor -B is activated in this sequence of events, possibly leading to arteriosclerosis (24, 25) . The accumulation of advanced glycation end products is also greatly accelerated among diabetic patients (25) . This might further promote chronic inflammation, especially among diabetic patients with ESRD.
TnT levels proved to be a surprisingly strong predictor, even among patients who died as a result of infection. We confirmed the effect of TnT on overall and cardiovascular mortality rates (9 -11); however, the effect on infectious disease-related mortality rates is new. The observation is perhaps not entirely unexpected, because TnT levels were observed to predict rates of sepsis-related death among patients without preexisting renal disease (27) . TnT levels presumably reflect cardiac malfunction, because the protein originates in cardiomyocytes.
Among patients with sepsis, myocardial performance is particularly compromised, perhaps because of myocardial depressant factors (28) . Myocardium confronted with uremia might be particularly prone to leak TnT and related proteins (29 -31) . Our findings draw attention to the fact that the heart is intimately compromised even among patients who do not die as a direct result of cardiovascular causes.
We were interested in the finding that D-dimer levels predicted all-cause mortality rates among hemodialysis patients. In a recent report, eight inflammatory or procoagulant factors were evaluated by using baseline data from the Cardiovascular Health Study, a population-based cohort study of 5888 older subjects (32) . CrP, fibrinogen, factor VIIc, factor VIIIc, interleukin-6, intercellular adhesion molecule-1, plasmin-antiplasmin complex, and D-dimer levels were measured. The investigators then compared their subjects on the basis of renal function and observed that renal insufficiency was independently associated with elevations in the levels of inflammatory and procoagulant biomarkers, including D-dimers. Their results are in accord with the findings of earlier reports that suggested that D-dimers may indicate the presence of cardiovascular disease (33, 34) . D-dimers are fibrin degradation products and reflect an activated coagulation pathway (33, 34) .
We think that our findings suggest future perspectives. For example, the high risk exhibited by diabetic patients might be more clearly defined on the basis of CrP levels, D-dimer levels, and the level of residual renal function. Preserving residual renal function, perhaps by initially treating patients with ESRD with peritoneal dialysis, might be a consideration. We suggest that TnT and D-dimer levels, in addition to serum albumin and CrP levels, should be monitored among patients undergoing hemodialysis. A lack of residual renal function indicates a particularly high infectious disease-related mortality risk.
